These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 1338524

  • 1. [Demethyl-vancomycin in treatment of resistant staphylococcal infections. A clinical evaluation].
    Zhu F.
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):562-4, 575. PubMed ID: 1338524
    [Abstract] [Full Text] [Related]

  • 2. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B.
    Clin Infect Dis; 2002 Jun 01; 34(11):1481-90. PubMed ID: 12015695
    [Abstract] [Full Text] [Related]

  • 3. The role of vancomycin in the treatment paradigm.
    Stevens DL.
    Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S51-7. PubMed ID: 16323121
    [Abstract] [Full Text] [Related]

  • 4. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G, Moellering RC.
    Clin Infect Dis; 2008 Jun 01; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [Abstract] [Full Text] [Related]

  • 5. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
    Torun MM, Bahar H, Demirci M, Altaş K, Bağdatli Y, Kocazeybek B, Kapi M, Hiramatsu K.
    Int J Antimicrob Agents; 2005 Dec 01; 26(6):508-10. PubMed ID: 16256313
    [No Abstract] [Full Text] [Related]

  • 6. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN.
    Clin Microbiol Infect; 2008 Mar 01; 14 Suppl 2():3-9. PubMed ID: 18226084
    [Abstract] [Full Text] [Related]

  • 7. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
    Sakoulas G, Moellering RC, Eliopoulos GM.
    Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S40-50. PubMed ID: 16323119
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG, Basuino L, Chambers HF.
    Antimicrob Agents Chemother; 2005 Aug 01; 49(8):3163-5. PubMed ID: 16048918
    [Abstract] [Full Text] [Related]

  • 9. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
    Itani KM, Weigelt J, Li JZ, Duttagupta S.
    Int J Antimicrob Agents; 2005 Dec 01; 26(6):442-8. PubMed ID: 16289514
    [Abstract] [Full Text] [Related]

  • 10. Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin.
    Burnie J, Matthews R, Jiman-Fatami A, Gottardello P, Hodgetts S, D'arcy S.
    Clin Infect Dis; 2000 Sep 01; 31(3):684-9. PubMed ID: 11017816
    [Abstract] [Full Text] [Related]

  • 11. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A.
    Arch Intern Med; 2006 Oct 23; 166(19):2138-44. PubMed ID: 17060545
    [Abstract] [Full Text] [Related]

  • 12. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
    Siaperas P, Pefanis A, Iliopoulos D, Katsarolis I, Kyroudi-Voulgari A, Donta I, Karayiannakos P, Giamarellou H.
    Antimicrob Agents Chemother; 2001 Dec 23; 45(12):3531-7. PubMed ID: 11709335
    [Abstract] [Full Text] [Related]

  • 13. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
    Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC.
    J Infect; 2007 May 23; 54(5):427-34. PubMed ID: 17070598
    [Abstract] [Full Text] [Related]

  • 14. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A, Karmakar PS, Pal J, Chakraborty N, Debnath NB, Mukherjee JD.
    J Indian Med Assoc; 2009 Jan 23; 107(1):21-2, 24-5. PubMed ID: 19588683
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
    Huang YT, Hsiao CH, Liao CH, Lee CW, Hsueh PR.
    J Clin Microbiol; 2008 Mar 23; 46(3):1132-6. PubMed ID: 18199793
    [Abstract] [Full Text] [Related]

  • 20. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D, Toshkova K, Gavrilova V.
    Vutr Boles; 2000 Mar 23; 32(2):35-40. PubMed ID: 11227664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.